{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-015604","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2024-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.358461+00:00","generated_at":"2026-06-06T00:44:39.506301+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Agenus proposes 1-for-20 reverse stock split to regain Nasdaq $1 compliance","bullets":["Reverse stock split at 1:20 ratio proposed to lift share price above $1 Nasdaq minimum.","Special shareholder meeting set for April 3, 2024 to vote on the split.","Company plans BLA submission for metastatic colorectal cancer with potential 2025 launch.","Also exploring monetization of royalty assets and real estate to strengthen finances.","Engaged in discussions with pharmaceutical companies for potential cash infusions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-015604","json":"https://secwatch.observer/filing/0000950170-24-015604.json","markdown":"https://secwatch.observer/filing/0000950170-24-015604.md","text":"https://secwatch.observer/filing/0000950170-24-015604.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024015604/0000950170-24-015604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024015604/agen-20240215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T00:44:39.506301+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}